This federal contract award is for the delivery of Ozempic, a medication used to manage diabetes, to the Defense Logistics Agency (DLA). The $13,391.90 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 23, 2024, with a completion date of December 24, 2024. The contract is not designated as a set-aside. AmerisourceBergen is a key supplier of pharmaceutical products and medical supplies to federal healthcare programs, including the military and veterans' health systems. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of essential medical commodities to support military healthcare operations globally.
Generated 3/24/25, 9:44 AM